Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$191.17 - $325.63 $306,254 - $521,659
1,602 New
1,602 $521,000
Q3 2023

Nov 13, 2023

BUY
$194.33 - $283.97 $17.8 Million - $26 Million
91,680 Added 187.42%
140,598 $28 Million
Q2 2023

Aug 14, 2023

BUY
$223.05 - $302.68 $5.08 Million - $6.89 Million
22,767 Added 87.06%
48,918 $14 Million
Q1 2023

May 15, 2023

SELL
$175.41 - $217.92 $10.7 Million - $13.3 Million
-61,042 Reduced 70.01%
26,151 $5.67 Million
Q4 2022

Feb 09, 2023

SELL
$204.38 - $296.82 $9.62 Million - $14 Million
-47,082 Reduced 35.06%
87,193 $17.9 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $3.91 Million - $6.22 Million
20,024 Added 17.53%
134,275 $37.3 Million
Q2 2022

Aug 12, 2022

BUY
$115.91 - $214.48 $8.86 Million - $16.4 Million
76,411 Added 201.93%
114,251 $21.8 Million
Q1 2022

May 13, 2022

SELL
$127.96 - $207.36 $3.17 Million - $5.13 Million
-24,762 Reduced 39.55%
37,840 $7.85 Million
Q4 2021

Feb 08, 2022

SELL
$165.13 - $241.83 $693,711 - $1.02 Million
-4,201 Reduced 6.29%
62,602 $11.2 Million
Q3 2021

Nov 15, 2021

BUY
$163.99 - $235.57 $55,428 - $79,622
338 Added 0.51%
66,803 $13.8 Million
Q2 2021

Aug 16, 2021

BUY
$131.45 - $201.49 $2.17 Million - $3.33 Million
16,506 Added 33.04%
66,465 $12.6 Million
Q1 2021

May 14, 2021

BUY
$92.73 - $142.05 $1.16 Million - $1.77 Million
12,463 Added 33.24%
49,959 $6.51 Million
Q4 2020

Feb 02, 2021

BUY
$67.44 - $103.72 $265,241 - $407,930
3,933 Added 11.72%
37,496 $3.89 Million
Q3 2020

Nov 05, 2020

SELL
$42.79 - $75.8 $876,082 - $1.55 Million
-20,474 Reduced 37.89%
33,563 $2.54 Million
Q2 2020

Jul 22, 2020

BUY
$27.25 - $47.53 $1.47 Million - $2.57 Million
54,037 New
54,037 $2.56 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.